All patients | Men | Women | |||||||
---|---|---|---|---|---|---|---|---|---|
Obesitya | Non-obesity | P a | Obesitya | Non-obesity | P a | Obesitya | Non-obesity | P a | |
N | 49 | 235 | 13 | 146 | 36 | 89 | |||
Age (years) | 45 (35, 53) | 42 (31, 51) | 0.11b | 50 (34, 58) | 43 (32, 51) | 0.072 b | 45 (35–51) | 40 (30–48) | 0.18b |
Diabetes duration (years) | 22 (14, 28) | 20 (11, 31) | 0.64b | 21 (8, 31) | 20 (12, 32) | 0.92 b | 23 (15–29) | 18 (10–29) | 0.27b |
Depression (≥ 8p)c | 6 (12) | 23 (10) | 0.61 | 2 (15) | 13 (9) | 0.35 | 4 (11) | 10 (11) | >0.99 |
Anxiety (≥ 8p)d | 25 (51) | 71 (30) | 0.007 | 3 (31) | 35 (24) | 0.74 | 21 (58) | 36 (40) | 0.078 |
Alexithymia (≥ 61p)e | 12 (24) | 30 (13) | 0.046 | 3 (23) | 16 (11) | 0.19 | 9 (25) | 14 (16) | 0.31 |
High DIF (≥23 p)e | 12 (24) | 20 (8) | 0.005 | 4 (31) | 8 (6) | 0.009 | 8 (22) | 12 (14) | 0.28 |
High DDF (≥ 18 p)e | 4 (8) | 26 (11) | 0.80 | 1 (8) | 16 (11) | >0.99 | 3 (8) | 10 (11) | 0.72 |
High EOT (≥ 27 p)e | 2 (4) | 29 (12) | 0.13 | 0 (0) | 23 (16) | 0.22 | 2 (6) | 6 (7) | >0.99 |
High self-emancipation (≥ 66 p)f | 6 (12) | 21 (9) | 0.43 | 3 (23) | 15 (10) | 0.18 | 3 (9) | 6 (7) | 0.72 |
Low self-affirmation (≤ 38 p)f | 9 (19) | 23 (10) | 0.13 | 1 (8) | 8 (6) | 0.55 | 8 (23) | 15 (17) | 0.61 |
Low self-love (≤ 40 p)f | 8 (17) | 23 (10) | 0.21 | 2 (15) | 9 (6) | 0.23 | 6 (17) | 14 (16) | >0.99 |
Low self-protection (≤ 30 p)f | 5 (10) | 23 (10) | >0.99 | 1 (8) | 18 (13) | >0.99 | 4 (11) | 5 (6) | 0.28 |
Low self-control (≤ 28 p)f | 8 (17) | 25 (11) | 0.32 | 2 (15) | 16 (11) | 0.65 | 6 (17) | 9 (10) | 0.36 |
High self-blame (≥ 52 p)f | 9 (19) | 28 (12) | 0.24 | 1 (8) | 8 (6) | 0.55 | 8 (23) | 20 (23) | >0.99 |
High self-hate (≥ 50 p)f | 10 (21) | 20 (9) | 0.021 | 1 (8) | 7 (5) | 0.51 | 9 (26) | 13 (15) | 0.20 |
High self-neglect (≥ 48 p)f | 7 (14) | 24 (10) | 0.45 | 1 (8) | 17 (12) | >0.99 | 6 (17) | 7 (8) | 0.19 |
Smokingg | 4 (9) | 24 (11) | 0.80 | 1 (8) | 17 (12) | >0.99 | 3 (9) | 7 (8) | >0.99 |
Physical inactivityh | 9 (19) | 22 (10) | 0.084 | 2 (15) | 16 (11) | 0.65 | 7 (20) | 6 (7) | 0.054 |
Cardiovascular complications | 5 (10) | 5 (2) | 0.016 | 1 (8) | 5 (3) | 0.41 | 4 (11) | 0 | 0.006 |
Clinical psychiatric diagnoses | 11 (22) | 27 (11) | 0.062 | 1 (8) | 15 (10) | >0.99 | 10 (28) | 12 (14) | 0.071 |
Antidepressants | 8 (16) | 15 (6) | 0.038 | 1 (8) | 10 (7) | >0.99 | 7 (19) | 5 (6) | 0.038 |
MDII and OAA | 13 (27) | 4 (2) | <0.001 | 3 (23) | 3 (2) | 0.009 | 10 (28) | 1 (1) | <0.001 |
CSII | 1 (2) | 25 (10) | 0 | 13 (9) | 1 (3) | 12 (14) | |||
MDII | 35 (71) | 206 (88) | 10 (77) | 130 (89) | 25 (69) | 76 (85) |